Final Exam - Textbook Questions Flashcards

1
Q
1.	Which of the following are NOT steps in the medication-use process?
A.	Transcribing
B.	Diagnosis
C.	Monitoring
D.	Dispensing
E.	Prescribing
A

B. Diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  1. The pharmacy practice model is one where the pharmacists are chiefly involved in clinical activities associated with medicals teams on the nursing units.
    a. True
    b. False
A

b. False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  1. Which of the following key components influence the type of pharmacy practice model utilized in an institution?
    a. The culture of the department
    b. The pharmacists working in the pharmacy
    c. The technicians
    d. Availability of automation and technology
    e. All of the above
A

e. All of the above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  1. The practice of pharmacy in institutions consists of clinical pharmacists working alone to identify and resolve drug related problems within the drug related problems within the drug use system.
    a. True
    b. False
A

b. False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  1. The pharmacist role in an inpatient critical care unit differs from a general inpatient care unit because the acuity level is higher in a critical care unit.
    a. True
    b. False
A

a. True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  1. Which of the following are developed by the pharmacy profession and imposed on pharmacy professionals voluntarily?
    a. Regulations
    b. Policies and procedures
    c. Laws
    d. Practice standards
    e. None of the above
A

d. Practice standards

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  1. Who usually has ultimate responsibility and authority for all aspects of pharmacy service?
    a. The chief executive officer of the institution
    b. The pharmacy staff
    c. The medical staff
    d. The institution’s board of directors
    e. The director of pharmacy
A

e. The director of pharmacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  1. The difference between a “for profit hospital” an a “non profit hospital” is that non profit hospitals do not make any money.
    a. True
    b. False
A

b. False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  1. Which of the following events furthered the progression of hospital pharmacy in the U.S.?
    a. An influx of immigrants in the late 1800s
    b. The Civil War
    c. Prohibition
    d. All of the above
A

d. All of the above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. The majority of hospitals in the U.S. today are fully digital (without paper records).
    a. True
    b. False
A

b. False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  1. Pharmacy and Therapeutics committees (P&T) are a relatively recent phenomenon in institutional pharmacy.
    a. True
    b. False
A

b. False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  1. Which of the following is NOT a professional organization associated with institutional pharmacy practice?
    a. ASHP
    b. ASCP
    c. NACDS
    d. All of the above pharmacy organizations represent the pharmacists who are associated with instituitons
A

a. NACDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  1. Hospital pharmacists have a significant impact on the clinical and scientific focus of curricula in the U.S. pharmacy schools?
    a. True
    b. False
A

a. True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  1. _________ are advisory documents developed by pharmacists that offer advice on the minimum requirements or optimal method for addressing an important issue or problem in hospitals.
    a. Practice standards
    b. Regulations
    c. Laws
    d. Reports
A

a. Practice standards

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  1. Accreditation and certification are very similar in their purpose.
    a. True
    b. False
A

a. True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  1. The Joint Commission’s mission is to improve the safety and quality of care of health care in institutions.
    a. True
    b. False
A

a. True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q
  1. Joint Commission accredited organizations are eligible automatically to participate in the Medicare program.
    a. True
    b. False
A

a. True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q
  1. _____________ enforces the Federal Food Drug and Cosmetic Act
    a. FDA
    b. DEA
    c. OSHA
    d. The Joint Commission
A

a. FDA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
  1. Which of the following is NOT a governmental organization?
    a. CDC
    b. USP
    c. OSHA
    d. DEA
A

b. USP

20
Q
  1. Any health systems pharmacist can contribute to the development of ASHP standards of practice.
    a. True
    b. False
A

a. True

21
Q
  1. The IOM report, To Err is Human: Building a Safer Health System, was the stimulus for ASHP to begin developing standards on safe medication practices in institutions.
    a. True
    b. False
A

b. False

22
Q
  1. Which of the following professional organization’s primary mission is to represent pharmacists serving senior citizens?
    a. ASCP
    b. ASHP
    c. APhA
    d. ACCP
A

a. ASCP

23
Q
  1. The following elements of the formulary system are used to manage drug costs (select all that apply)
    a. Therapeutic interchange
    b. Nonformulary drug use
    c. Genetic substitution
    d. Drug therapy guidelines
A

a. Therapeutic interchange
c. Genetic substitution
d. Drug therapy guidelines

24
Q
  1. Once the formulary has been established, no further action is required except to add new pharmaceutical entities as they become available.
    a. True
    b. False
A

b. False

25
Q
  1. P&T committees may have subcommittees to facilitate specific objectives. Examples of subcommittees include (select all that apply)
    a. Medication Safety
    b. Antibiotic/Infectious Disease
    c. Laboratory Testing
A

a. Medication Safety

b. Antibiotic/Infectious Disease

26
Q
  1. When selecting a drug for formulary addition, which of the following should be considered? (select all that apply)
    a. Does it come in unit dose packaging?
    b. Is it a duplication of an existing formulary agent?
    c. How should it be used?
    d. It is safer than similar agents already on formulary?
    e. Will the vendor give the health-system free samples?
A

b. Is it a duplication of an existing formulary agent?
c. How should it be used?
d. It is safer than similar agents already on formulary?

27
Q
  1. The _____________ is responsible for overnight of all medication use in the hospital.
A

a. Pharmacy and Therapeutic Committee (P&T)

28
Q
  1. Medication use evaluation is a systematic approach to monitoring drug therapy and associated outcomes. The optimal data collection period is _____________
A

a. Concurrent or during the patient visit

29
Q
  1. The Pharmacy and Therapeutics Committee is a multi-disciplinary committee including physicians, pharmacists, and nurses.
    a. True
    b. False
    The rationale for
A

a. True

30
Q
  1. The rationale for completing a drug use evaluation is to:
    a. Validate drug use is safe and appropriate
    b. Determine the most common prescribers of a specific drug
    c. Educate the nursing staff on appropriate medical administration
A

a. Validate drug use is safe and appropriate

31
Q
  1. The pharmacist is NOT responsible for assuring the following:
    a. Quality, quantity, and source of all medications in the health-system
    b. All medications in the health system meet FDA and USP standards
    c. All brands of formulary agents are available for use in the health system
A

c. All brands of formulary agents are available for use in the health system

32
Q
  1. Drug-related problems include medication errors, adverse drug reactions, medication side effects, and adverse drug events.
    a. True
    b. False
A

a. True

33
Q
  1. Which of the following is never caused by a medication error?
    a. Side effect
    b. Adverse drug event
    c. Adverse drug reaction
    d. Allergic reaction
A

a. Side effect

34
Q
  1. Which of the following sometimes directly results in drug-related morbidity?
    a. A latent injury
    b. A potential injury
    c. An adverse drug event
    d. An allergic reaction
    e. An adverse drug reaction
A

c. An adverse drug event
d. An allergic reaction
e. An adverse drug reaction

35
Q
  1. Pharmacists in health system practice are responsible for errors in dispensing.
    a. True
    b. False
A

a. True

36
Q
  1. In which step of the PDSA cycle is a quality problem statement developed?
    a. Plan
    b. Do
    c. Study
    d. Act
A

a. Plan

37
Q
  1. Floor stock systems are no longer used in institutional pharmacy practice.
    a. True
    b. False
A

b. False

38
Q
  1. Who is responsible for maintaining MARS?
    a. Nurses
    b. Pharmacists
    c. Physicians
A

a. Nurses

39
Q
  1. CPOE has been widely adopted and implemented in U.S. Hospitals.
    a. True
    b. False
A

a. False

40
Q
  1. A drug interaction alert is a form of clinical decision support.
    a. True
    b. False
A

a. True

41
Q
  1. Which of the following organizations supports CPOE?
    a. CMS
    b. DHHS
    c. Leapfrog group
    d. IOM
    e. All of the above
A

e. All of the above

42
Q
  1. CPOE and e-prescribing are synonymous terms.
    a. True
    b. False
A

b. False

43
Q
  1. The _______________ is developed and maintained by the P&T committee and the cornerstone of the purchasing and inventory control system.
A

a. Formulary

44
Q
  1. __________ contracts are agreements between a health system pharmacy and a wholesaler where the pharmacy agrees to purchase most of its pharmaceuticals from a single wholesale company.
A

a. Primer vendor

45
Q
  1. Which of the following drug classes can be returned to suppliers after expiration?
    a. Prepackaged drugs
    b. Chemical-grade products used in extemporaneous compounding
    c. Investigational drugs
    d. Controlled substances
A

c. Investigational drugs